Michael Gold to Papillomavirus Infections
This is a "connection" page, showing publications Michael Gold has written about Papillomavirus Infections.
Connection Strength
3.039
-
Observed Colposcopy Practice in US Community-Based Clinics: The Retrospective Control Arm of the IMPROVE-COLPO Study. J Low Genit Tract Dis. 2019 Apr; 23(2):110-115.
Score: 0.575
-
Guidelines for Cervical Cancer Screening in Immunosuppressed Women Without HIV Infection. J Low Genit Tract Dis. 2019 Apr; 23(2):87-101.
Score: 0.575
-
High-risk human papillomavirus detection in women with low-grade squamous intraepithelial lesions or higher-grade cytology using the Cervista HPV HR test. J Low Genit Tract Dis. 2013 Jan; 17(1):51-7.
Score: 0.373
-
Association of HPV35 with cervical carcinogenesis among women of African ancestry: Evidence of viral-host interaction with implications for disease intervention. Int J Cancer. 2020 11 15; 147(10):2677-2686.
Score: 0.155
-
Cytologic patterns of cervical adenocarcinomas with emphasis on factors associated with underdiagnosis. Cancer Cytopathol. 2018 11; 126(11):950-958.
Score: 0.139
-
A prospective study of risk-based colposcopy demonstrates improved detection of cervical precancers. Am J Obstet Gynecol. 2018 06; 218(6):604.e1-604.e8.
Score: 0.133
-
A Common Clinical Dilemma: Management of Abnormal Vaginal Cytology and Human Papillomavirus Test Results. J Low Genit Tract Dis. 2016 Apr; 20(2):119-25.
Score: 0.117
-
A common clinical dilemma: Management of abnormal vaginal cytology and human papillomavirus test results. Gynecol Oncol. 2016 05; 141(2):364-370.
Score: 0.116
-
Evaluation of clinical performance of a novel urine-based HPV detection assay among women attending a colposcopy clinic. J Clin Virol. 2014 Aug; 60(4):414-7.
Score: 0.102
-
Comparison of human papillomavirus detections in urine, vulvar, and cervical samples from women attending a colposcopy clinic. J Clin Microbiol. 2014 Jan; 52(1):187-92.
Score: 0.099
-
The role of co-factors in the progression from human papillomavirus infection to cervical cancer. Gynecol Oncol. 2013 Feb; 128(2):265-70.
Score: 0.092
-
Heterogeneity of high-grade cervical intraepithelial neoplasia related to HPV16: implications for natural history and management. Int J Cancer. 2013 Jan 01; 132(1):148-54.
Score: 0.089
-
Human papillomavirus load measured by Linear Array correlates with quantitative PCR in cervical cytology specimens. J Clin Microbiol. 2012 May; 50(5):1564-70.
Score: 0.088
-
Clinical trial and post-licensure safety profile of a prophylactic human papillomavirus (types 6, 11, 16, and 18) l1 virus-like particle vaccine. Pediatr Infect Dis J. 2010 Feb; 29(2):95-101.
Score: 0.076
-
Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinants. Int J Cancer. 2009 Nov 01; 125(9):2151-8.
Score: 0.075
-
Human papillomavirus cofactors by disease progression and human papillomavirus types in the study to understand cervical cancer early endpoints and determinants. Cancer Epidemiol Biomarkers Prev. 2009 Jan; 18(1):113-20.
Score: 0.071
-
Adolescent cervical dysplasia: histologic evaluation, treatment, and outcomes. Am J Obstet Gynecol. 2007 Aug; 197(2):141.e1-6.
Score: 0.064
-
Squamous metaplasia of the endometrium associated with HPV 6 and 11. Gynecol Oncol. 1997 Jul; 66(1):141-5.
Score: 0.032
-
Multiple biopsies and detection of cervical cancer precursors at colposcopy. J Clin Oncol. 2015 Jan 01; 33(1):83-9.
Score: 0.027
-
Performance of p16/Ki-67 immunostaining to detect cervical cancer precursors in a colposcopy referral population. Clin Cancer Res. 2012 Aug 01; 18(15):4154-62.
Score: 0.022
-
Age-appropriate use of human papillomavirus vaccines in the U.S. Gynecol Oncol. 2009 Aug; 114(2):365-9.
Score: 0.018